CA50644-3A - 0x0000000000006ED4

Healthy Males & Females

Ruler

* Stipend may pay up to reflected amount.
Start Date: 
August 5, 2026 - 3:00pm
End Date: 
August 15, 2026 - 9:30am

Study Details

Study Number: CA50644
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to treat asthma and COPD (chronic obstructive pulmonary disease).
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Tuesday 7/28/2026
Wednesday 7/29/2026
Monday 8/3/2026
Tuesday 8/4/2026

Doctor Exam Dates:

Event Day Event Date
Tuesday 7/28/2026
Wednesday 7/29/2026
Monday 8/3/2026
Tuesday 8/4/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 8/5/2026 3:00:00 PM Sunday 8/9/2026 9:30:00 AM 1 Lincoln
Return Saturday 8/15/2026 8:30:00 AM Saturday 8/15/2026 9:30:00 AM 1 Lincoln